Skip to main content

A population-based study of surgery for spinal metastases. Survival rates and complications

Finkelstein JA, Zaveri G, Wai E, Vidmar M, Kreder H, Chow E. J Bone Joint Surg Br. 2003; 85(7):1045-50.


The management of spinal metastases is palliative and aimed at improving quality of life at an acceptable risk. This population study uses administrative databases and measures survivorship and complication rates after surgery for spinal metastases. The effects of various potential predictor variables were evaluated. We identified 987 patients with a median survival for all types of cancer of 227 days. The one and three-month mortality was 9% and 29%, respectively. Increasing age, male gender and primary lung cancer were significant risk factors for death within 30 days of surgery. A preoperative neurological deficit contributed a 19% increase in mortality and a 71% increase in the risk of postoperative wound infection. We found an overall major complication rate of 27%. This information will provide patients, families and clinicians with objective data which will help in the choice of treatment and the understanding of the surgical risk and outcome.

View full text

Keywords: Surgery Treatment outcomes Treatments in oncology Cancer

×